Increased competition means life science businesses and labs must be exceptional places to work, and of course they must also impress current and prospective customers and the regulator..
Sometimes we find something which human expertise has not spotted.Generative design can create unexpected options with high value.. We are now working on making Chips available to very large numbers of users through a web interface, to use generative design for pharmaceutical plants.
We are also associating process simulation data with those Chips, so that we can look at throughput, and use throughput to define what Chips we need..The Chip as future enabler.We are often asked what ‘Chip’ stands for.
It doesn't stand for anything.It's based on the idea of a microchip within a computer.
The microchip is the bit that does the hard work.
It's the intelligent bit and the bit that adds value.. Chips are enabling tools that do a lot of work and add a lot of value.Difficulties with Carbon Capture.
There are limitations with these carbon capture methods, however, as CCS by itself isn’t enough to bring us to the designated targets for the industry.CCU is the better of the two methods to take meaningful steps towards carbon neutrality, as it puts the carbon to use straight away with less risk of it escaping.
The issue with these methods is that there is still work to be done on the technology and estimations for using the captured carbon in directly transforming it into hydrocarbons.. A good measure to show how close a technology is to being used is the technology readiness level (TRL).This is a scale of 1-9, where 1 is the concept and 9 is a system ready to be implemented.
(Editor: Adjustable Ovens)